HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
1-n-butyl-3-n-propylxanthine
Also Known As:
1-BPX; XT-44
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Alkaloids: 5398
Xanthines: 123
1-n-butyl-3-n-propylxanthine: 1
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Purines: 651
Purinones: 2
Xanthines: 123
1-n-butyl-3-n-propylxanthine: 1
Related Diseases
1.
Osteoporosis
04/01/1999 - "
These results indicate that XT-44 could be a candidate as a therapeutic drug for treating osteopenia including osteoporosis.
"
2.
Metabolic Bone Diseases (Osteopenia)
04/01/1999 - "
These results indicate that XT-44 could be a candidate as a therapeutic drug for treating osteopenia including osteoporosis.
"
04/01/1999 - "
Effects of XT-44, a phosphodiesterase 4 inhibitor, in osteoblastgenesis and osteoclastgenesis in culture and its therapeutic effects in rat osteopenia models.
"
Related Drugs and Biologics
1.
Phosphodiesterase 4 Inhibitors
2.
Therapeutic Uses